{
"info": {
"nct_id": "NCT05236582",
"official_title": "Herombopag for Chemotherapy-induced Thrombocytopenia: a Prospective Multi-center One-arm Study in Solid Tumors",
"inclusion_criteria": "* Aged ≥18 years old, male or female;\n* Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT); Ineffective after repeated treatment with rhTPO or IL-11;\n* Stop radiotherapy or chemotherapy for more than 1 month;\n* Platelet counts <30 ×10^9/L, and bleeding tendency;\n* Estimated survival period ≥ 6 months;\n* People who are willing to sign the informed consent voluntarily and follow the research program.\n* Liver and kidney function<1.5×upper limit of normal, qualified for physical examination;\n* Subject is practicing an acceptable method of contraception. Women of childbearing potential must have a negative serum pregnancy test in the whole study;\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Those with uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors, liver failure, heart failure, kidney failure and other diseases;\n* Patients with poor compliance;\n* Positive serology for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and/or hepatitis D virus (HDV), Syphilis; Positive for Epstein-Barr Virus DNA, Cytomegalovirus DNA;\n* Accompanied by extensive and severe bleeding, such as hemoptysis, upper gastrointestinal bleeding, intracranial hemorrhage, etc.\n* There is currently a heart disease requiring treatment or a poorly controlled hypertension judged by the investigator;\n* Patients with thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis;\n* Those who have received allogeneic stem cell transplantation or organ transplantation in the past;\n* Patients with mental disorders who cannot normally obtain informed consent and undergo trials and follow-up;\n* Patients whose toxic symptoms caused by treatment before participating in the trial have not disappeared;\n* Other serious diseases that may restrict participants from participating in this trial (such as diabetes; severe heart failure; myocardial obstruction or unstable arrhythmia or unstable angina in the past 6 months; gastric ulcers; mobility Autoimmune diseases, etc.);\n* Patients with sepsis or patients with other irregular bleeding;\n* Patients taking antiplatelet drugs at the same time;\n* Pregnant women, suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening) and breastfeeding patients;\n* Pre-existing cardiac disease, including congestive heart failure of New York Heart Association [NYHA] Grade III/IV, arrhythmia requiring treatment or myocardial infarction within the last 6 months. No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation), or patients with a QT >450msec or QTc > 480 for patients with a Bundle Branch Block;\n* Researchers believe that patients should not participate in the test of any other condition.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Aged ≥18 years old, male or female;",
"criterions": [
{
"exact_snippets": "Aged ≥18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "male or female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "allowed genders",
"expected_value": [
"male",
"female"
]
}
]
}
]
},
{
"line": "* Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT); Ineffective after repeated treatment with rhTPO or IL-11;",
"criterions": [
{
"exact_snippets": "Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT)",
"criterion": "chemotherapy-induced thrombocytopenia (CIT)",
"requirements": [
{
"requirement_type": "diagnostic criteria",
"expected_value": "conform"
}
]
},
{
"exact_snippets": "Ineffective after repeated treatment with rhTPO or IL-11",
"criterion": "treatment with rhTPO or IL-11",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": "ineffective"
}
]
}
]
},
{
"line": "* Stop radiotherapy or chemotherapy for more than 1 month;",
"criterions": [
{
"exact_snippets": "Stop radiotherapy ... for more than 1 month",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "cessation duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "Stop ... chemotherapy for more than 1 month",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "cessation duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Platelet counts <30 ×10^9/L, and bleeding tendency;",
"criterions": [
{
"exact_snippets": "Platelet counts <30 ×10^9/L",
"criterion": "platelet counts",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 30,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "bleeding tendency",
"criterion": "bleeding tendency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Estimated survival period ≥ 6 months;",
"criterions": [
{
"exact_snippets": "Estimated survival period ≥ 6 months",
"criterion": "survival period",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* People who are willing to sign the informed consent voluntarily and follow the research program.",
"criterions": [
{
"exact_snippets": "willing to sign the informed consent voluntarily",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "follow the research program",
"criterion": "research program adherence",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* Liver and kidney function<1.5×upper limit of normal, qualified for physical examination;",
"criterions": [
{
"exact_snippets": "Liver ... <1.5×upper limit of normal",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "function level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "× upper limit of normal"
}
}
]
},
{
"exact_snippets": "kidney function<1.5×upper limit of normal",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "function level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "× upper limit of normal"
}
}
]
},
{
"exact_snippets": "qualified for physical examination",
"criterion": "physical examination",
"requirements": [
{
"requirement_type": "qualification",
"expected_value": true
}
]
}
]
},
{
"line": "* Subject is practicing an acceptable method of contraception. Women of childbearing potential must have a negative serum pregnancy test in the whole study;",
"criterions": [
{
"exact_snippets": "Subject is practicing an acceptable method of contraception",
"criterion": "contraception method",
"requirements": [
{
"requirement_type": "acceptability",
"expected_value": true
}
]
},
{
"exact_snippets": "Women of childbearing potential must have a negative serum pregnancy test",
"criterion": "serum pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Those with uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors, liver failure, heart failure, kidney failure and other diseases;",
"criterions": [
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors",
"criterion": "extensive metastasis of malignant tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... liver failure",
"criterion": "liver failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... heart failure",
"criterion": "heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... kidney failure",
"criterion": "kidney failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with poor compliance;",
"criterions": [
{
"exact_snippets": "Patients with poor compliance",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "poor"
}
]
}
]
},
{
"line": "* Positive serology for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and/or hepatitis D virus (HDV), Syphilis; Positive for Epstein-Barr Virus DNA, Cytomegalovirus DNA;",
"criterions": [
{
"exact_snippets": "Positive serology for HIV",
"criterion": "HIV serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis B virus (HBV)",
"criterion": "hepatitis B virus (HBV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis C virus (HCV)",
"criterion": "hepatitis C virus (HCV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis D virus (HDV)",
"criterion": "hepatitis D virus (HDV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... Syphilis",
"criterion": "Syphilis serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive for Epstein-Barr Virus DNA",
"criterion": "Epstein-Barr Virus DNA",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive for ... Cytomegalovirus DNA",
"criterion": "Cytomegalovirus DNA",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Accompanied by extensive and severe bleeding, such as hemoptysis, upper gastrointestinal bleeding, intracranial hemorrhage, etc.",
"criterions": [
{
"exact_snippets": "extensive and severe bleeding",
"criterion": "bleeding",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "extensive and severe"
}
]
},
{
"exact_snippets": "hemoptysis",
"criterion": "hemoptysis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "upper gastrointestinal bleeding",
"criterion": "upper gastrointestinal bleeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "intracranial hemorrhage",
"criterion": "intracranial hemorrhage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* There is currently a heart disease requiring treatment or a poorly controlled hypertension judged by the investigator;",
"criterions": [
{
"exact_snippets": "heart disease requiring treatment",
"criterion": "heart disease",
"requirements": [
{
"requirement_type": "treatment requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "poorly controlled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "poorly controlled"
}
]
}
]
},
{
"line": "* Patients with thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis;",
"criterions": [
{
"exact_snippets": "thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis",
"criterion": "thrombotic diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "pulmonary embolism",
"criterion": "pulmonary embolism",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "thrombosis",
"criterion": "thrombosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "atherosclerosis",
"criterion": "atherosclerosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Those who have received allogeneic stem cell transplantation or organ transplantation in the past;",
"criterions": [
{
"exact_snippets": "received allogeneic stem cell transplantation",
"criterion": "allogeneic stem cell transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "received ... organ transplantation",
"criterion": "organ transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with mental disorders who cannot normally obtain informed consent and undergo trials and follow-up;",
"criterions": [
{
"exact_snippets": "mental disorders",
"criterion": "mental disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cannot normally obtain informed consent",
"criterion": "ability to obtain informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
},
{
"exact_snippets": "undergo trials and follow-up",
"criterion": "ability to undergo trials and follow-up",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients whose toxic symptoms caused by treatment before participating in the trial have not disappeared;",
"criterions": [
{
"exact_snippets": "toxic symptoms caused by treatment before participating in the trial have not disappeared",
"criterion": "toxic symptoms from prior treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Other serious diseases that may restrict participants from participating in this trial (such as diabetes; severe heart failure; myocardial obstruction or unstable arrhythmia or unstable angina in the past 6 months; gastric ulcers; mobility Autoimmune diseases, etc.);",
"criterions": [
{
"exact_snippets": "diabetes",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "severe heart failure",
"criterion": "severe heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "myocardial obstruction",
"criterion": "myocardial obstruction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "unstable arrhythmia",
"criterion": "unstable arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "unstable angina in the past 6 months",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "gastric ulcers",
"criterion": "gastric ulcers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "mobility Autoimmune diseases",
"criterion": "mobility autoimmune diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with sepsis or patients with other irregular bleeding;",
"criterions": [
{
"exact_snippets": "Patients with sepsis",
"criterion": "sepsis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "patients with other irregular bleeding",
"criterion": "irregular bleeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients taking antiplatelet drugs at the same time;",
"criterions": [
{
"exact_snippets": "Patients taking antiplatelet drugs",
"criterion": "antiplatelet drug use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant women, suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening) and breastfeeding patients;",
"criterions": [
{
"exact_snippets": "Pregnant women",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "pregnant"
}
]
},
{
"exact_snippets": "suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening)",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "suspected"
},
{
"requirement_type": "test result",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "breastfeeding patients",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "status",
"expected_value": "breastfeeding"
}
]
}
]
},
{
"line": "* Pre-existing cardiac disease, including congestive heart failure of New York Heart Association [NYHA] Grade III/IV, arrhythmia requiring treatment or myocardial infarction within the last 6 months. No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation), or patients with a QT >450msec or QTc > 480 for patients with a Bundle Branch Block;",
"criterions": [
{
"exact_snippets": "Pre-existing cardiac disease",
"criterion": "pre-existing cardiac disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "congestive heart failure of New York Heart Association [NYHA] Grade III/IV",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "NYHA grade",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "arrhythmia requiring treatment",
"criterion": "arrhythmia",
"requirements": [
{
"requirement_type": "treatment requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "myocardial infarction within the last 6 months",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation)",
"criterion": "arrhythmia increasing thrombotic risk",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "QT >450msec",
"criterion": "QT interval",
"requirements": [
{
"requirement_type": "length",
"expected_value": {
"operator": ">",
"value": 450,
"unit": "msec"
}
}
]
},
{
"exact_snippets": "QTc > 480 for patients with a Bundle Branch Block",
"criterion": "QTc interval with Bundle Branch Block",
"requirements": [
{
"requirement_type": "length",
"expected_value": {
"operator": ">",
"value": 480,
"unit": "msec"
}
}
]
}
]
},
{
"line": "* Researchers believe that patients should not participate in the test of any other condition.",
"criterions": [
{
"exact_snippets": "patients should not participate in the test of any other condition",
"criterion": "participation in other condition tests",
"requirements": [
{
"requirement_type": "participation",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}